Novartis advances hunt for piece of Roche's growing MS empire
Novartis advances hunt for piece of Roche's growing MS empire
Reuters: Health
Swiss drugmaker Novartis on Friday threw down the gauntlet at Roche's multiple sclerosis franchise, touting study results for its MS hopeful ofatumumab that it hopes will muscle in on its crosstown rival's drug Ocrevus.
Reuters: Health
Swiss drugmaker Novartis on Friday threw down the gauntlet at Roche's multiple sclerosis franchise, touting study results for its MS hopeful ofatumumab that it hopes will muscle in on its crosstown rival's drug Ocrevus.
Comments
Post a Comment